Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo Xishan XiongLili FuChanglin Mei PRECLINICAL STUDIES 21 May 2008 Pages: 1 - 11
Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture Mario Luiz Conte da Frota JrElizandra BraganholJosé Cláudio Fonseca Moreira PRECLINICAL STUDIES 03 May 2008 Pages: 13 - 20
Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis Vennila SreedharanKarthik Kumar VenkatachalamNalini Namasivayam PRECLINICAL STUDIES 22 May 2008 Pages: 21 - 30
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib Roos L. OostendorpTessa BuckleJan H. M. Schellens PRECLINICAL STUDIES 01 May 2008 Pages: 31 - 40
Development of water soluble derivatives of cis-3, 4′, 5-trimethoxy-3′-aminostilbene for optimization and use in cancer therapy David E. DurrantJoanna RichardsRay M. Lee PRECLINICAL STUDIES 31 May 2008 Pages: 41 - 52
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy Christopher LieuLaura ChowLia Gore PHASE I STUDIES 11 July 2008 Pages: 53 - 62
A phase I trial of PTK787/ZK222584 in combination with pemetrexed and cisplatin in patients with advanced solid tumors Sunil SharmaBurgess FreemanNicholas Vogelzang PHASE I STUDIES 19 July 2008 Pages: 63 - 65
Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy Jae Hong SeoHwa Jung SungBum Hwan Koo PHASE II STUDIES 29 August 2008 Pages: 67 - 73
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer Hedy Lee KindlerHoward A. Burris IIIIra Anton Oliff PHASE II STUDIES 11 July 2008 Pages: 75 - 81
Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma Thomas W. FlaigFernando J. KimPaul D. Russ SHORT REPORT 18 June 2008 Pages: 83 - 87
Inhibition of protein synthesis by imexon reduces HIF-1α expression in normoxic and hypoxic pancreatic cancer cells Betty K. SamulitisTerry H. LandowskiRobert T. Dorr SHORT REPORT 08 July 2008 Pages: 89 - 98
